Vaccines for Children (VFC) FY26

Description

{"description":" The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of \npediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the \nmost cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children \n(VFC) program established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of \n1993 (OBRA '93), guarantees federal support for the purchase and supply of sufficient quantities of \nvaccine to the States to cover a defined group of children. The program helps assure the \nimplementation of effective immunization practices and proper use of vaccines to achieve higher \nimmunization coverage. Children (18 years-of-age or younger) who qualify for immunization through \nthe VFC purchase program include those who are(1) Medicaid-eligible, (2) without health insurance, \n(3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA '93), or (4) children \nwith health insurance, which does not cover the cost of vaccines, if they receive their immunizations at \na Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health \ncare providers who agree to certain requirements are eligible through the States to receive free vaccine \nthrough this VFC purchase program. The establishment of these contracts provides an opportunity to \nutilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those \navailable in the commercial marketplace. In addition, awardees may opt to purchase additional \nquantities of vaccine under any resulting contract to provide immunizations for children who are not \nfederally vaccine-eligible children using state and local funds. Offerors for this requirement must be \nmanufacturers of pediatric vaccines in accordance with 42 U.S.C. (S)1396s. The term "manufacturer" \nmeans any corporation, organization, or institution, whether public or private (including Federal, State, \nand local departments, agencies, and instrumentalities), which manufactures, imports, processes, or \ndistributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, \nimport, process, or distribute a vaccine. \n"} Solicitation Number: 000HCJBC-2025-95504 Type: Combined Synopsis/Solicitation Base Type: Combined Synopsis/Solicitation NAICS: 325412 Classification Code: 6505 Response Deadline: 2026-01-14T13:00:00-05:00 Office Address: ATLANTA, GA Place of Performance: Atlanta, Georgia, 30341 POC: James Sprigler, zbs6@cdc.gov POC: Chad Turner, ukr9@cdc.gov {"description":" The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of \npediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the \nmost cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children \n(VFC) program established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of \n1993 (OBRA '93), guarantees federal support for the purchase and supply of sufficient quantities of \nvaccine to the States to cover a defined group of children. The program helps assure the \nimplementation of effective immunization practices and proper use of vaccines to achieve higher \nimmunization coverage. Children (18 years-of-age or younger) who qualify for immunization through \nthe VFC purchase program include those who are(1) Medicaid-eligible, (2) without health insurance, \n(3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA '93), or (4) children \nwith health insurance, which does not cover the cost of vaccines, if they receive their immunizations at \na Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health \ncare providers who agree to certain requirements are eligible through the States to receive free vaccine \nthrough this VFC purchase program. The establishment of these contracts provides an opportunity to \nutilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those \navailable in the commercial marketplace. In addition, awardees may opt to purchase additional \nquantities of vaccine under any resulting contract to provide immunizations for children who are not \nfederally vaccine-eligible children using state and local funds. Offerors for this requirement must be \nmanufacturers of pediatric vaccines in accordance with 42 U.S.C. (S)1396s. The term "manufacturer" \nmeans any corporation, organization, or institution, whether public or private (including Federal, State, \nand local departments, agencies, and instrumentalities), which manufactures, imports, processes, or \ndistributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, \nimport, process, or distribute a vaccine. \n"}